Highly variable pharmacokinetics of dexmedetomidine during intensive care: a case report
Open Access
- 25 February 2010
- journal article
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 4 (1) , 73
Abstract
Dexmedetomidine is a selective and potent alpha2-adrenoceptor agonist licensed for use in the sedation of patients initially ventilated in intensive care units at a maximum dose rate of 0.7 mug/kg/h administered for up to 24 hours. Higher dose rates and longer infusion periods are sometimes required to achieve sufficient sedation. There are some previous reports on the use of long-term moderate to high-dose infusions of dexmedetomidine in patients in intensive care units, but none of these accounts have cited dexmedetomidine plasma concentrations. We describe the case of a 42-year-old Caucasian woman with severe hemorrhagic pancreatitis following laparoscopic cholecystectomy who received dexmedetomidine for 24 consecutive days at a maximum dose rate of 1.9 mug/kg/h. Samples for the measurement of dexmedetomidine concentrations in her plasma were drawn at intervals of eight hours. On average, the observed plasma concentrations were well in accordance with previous knowledge on the pharmacokinetics of dexmedetomidine. There was, however, marked variability in the concentration of dexmedetomidine in her plasma despite a stable infusion rate. The pharmacokinetics of dexmedetomidine appears to be highly variable during intensive care.Keywords
This publication has 6 references indexed in Scilit:
- Effects of Low and High Plasma Concentrations of Dexmedetomidine on Myocardial Perfusion and Cardiac Function in Healthy Male SubjectsAnesthesiology, 2006
- Prolonged use of dexmedetomidine in an infant with respiratory failure following living donor liver transplantationPediatric Anesthesia, 2006
- Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care †British Journal of Anaesthesia, 2002
- The Effects of Increasing Plasma Concentrations of Dexmedetomidine in HumansAnesthesiology, 2000
- Pharmacokinetics and interaction pharmacodynamics of dexmedetomidine in humansBest Practice & Research Clinical Anaesthesiology, 2000
- Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patientsCritical Care Medicine, 1999